nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicoumarol—NQO1—Carboplatin—esophageal cancer	0.44	0.497	CbGbCtD
Dicoumarol—NQO1—Cisplatin—esophageal cancer	0.376	0.425	CbGbCtD
Dicoumarol—CYP2C9—Capecitabine—esophageal cancer	0.0458	0.0518	CbGbCtD
Dicoumarol—CYP2C9—Cisplatin—esophageal cancer	0.0231	0.0261	CbGbCtD
Dicoumarol—GPR35—digestive system—esophageal cancer	0.012	0.211	CbGeAlD
Dicoumarol—CRYZ—bronchus—esophageal cancer	0.0058	0.102	CbGeAlD
Dicoumarol—CRYZ—trachea—esophageal cancer	0.00521	0.0914	CbGeAlD
Dicoumarol—CRYZ—digestive system—esophageal cancer	0.00448	0.0786	CbGeAlD
Dicoumarol—CRYZ—lung—esophageal cancer	0.00374	0.0656	CbGeAlD
Dicoumarol—NQO1—neck—esophageal cancer	0.0037	0.0648	CbGeAlD
Dicoumarol—NQO1—Transcriptional activation by NRF2—NFE2L2—esophageal cancer	0.00328	0.0564	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—esophageal cancer	0.00307	0.0529	CbGpPWpGaD
Dicoumarol—VKORC1—lung—esophageal cancer	0.00258	0.0452	CbGeAlD
Dicoumarol—CRYZ—lymph node—esophageal cancer	0.00256	0.0449	CbGeAlD
Dicoumarol—NQO1—epithelium—esophageal cancer	0.00251	0.0441	CbGeAlD
Dicoumarol—NQO1—bronchus—esophageal cancer	0.00248	0.0434	CbGeAlD
Dicoumarol—NQO1—smooth muscle tissue—esophageal cancer	0.00242	0.0425	CbGeAlD
Dicoumarol—NQO1—trachea—esophageal cancer	0.00222	0.039	CbGeAlD
Dicoumarol—NQO1—Estrogen metabolism—CYP1B1—esophageal cancer	0.00196	0.0338	CbGpPWpGaD
Dicoumarol—NQO1—Transcriptional activation by NRF2—HMOX1—esophageal cancer	0.00195	0.0336	CbGpPWpGaD
Dicoumarol—NQO1—digestive system—esophageal cancer	0.00191	0.0335	CbGeAlD
Dicoumarol—NQO1—Oxidative Stress—NFE2L2—esophageal cancer	0.00188	0.0324	CbGpPWpGaD
Dicoumarol—VKORC1—lymph node—esophageal cancer	0.00176	0.0309	CbGeAlD
Dicoumarol—NQO1—lung—esophageal cancer	0.0016	0.028	CbGeAlD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—BBC3—esophageal cancer	0.00138	0.0238	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—esophageal cancer	0.00134	0.023	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.00134	0.023	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—ALDH3A1—esophageal cancer	0.00122	0.021	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—HMOX1—esophageal cancer	0.00112	0.0193	CbGpPWpGaD
Dicoumarol—NQO1—lymph node—esophageal cancer	0.00109	0.0192	CbGeAlD
Dicoumarol—NQO1—NRF2 pathway—BLVRB—esophageal cancer	0.00109	0.0187	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—SOD2—esophageal cancer	0.00105	0.018	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CTNNA1—esophageal cancer	0.00103	0.0178	CbGpPWpGaD
Dicoumarol—NQO1—Regulation of ornithine decarboxylase (ODC)—PSME2—esophageal cancer	0.00102	0.0176	CbGpPWpGaD
Dicoumarol—NQO1—Regulation of ornithine decarboxylase (ODC)—PSME1—esophageal cancer	0.00102	0.0176	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—HSPA5—esophageal cancer	0.00095	0.0164	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.000927	0.016	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.000927	0.016	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—PRDX1—esophageal cancer	0.000924	0.0159	CbGpPWpGaD
Dicoumarol—CYP2C9—digestive system—esophageal cancer	0.000914	0.016	CbGeAlD
Dicoumarol—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—esophageal cancer	0.000829	0.0143	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—SLC39A6—esophageal cancer	0.000823	0.0142	CbGpPWpGaD
Dicoumarol—CYP2C9—CYP2E1 reactions—CYP2A6—esophageal cancer	0.000797	0.0137	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—ADH7—esophageal cancer	0.000786	0.0135	CbGpPWpGaD
Dicoumarol—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—esophageal cancer	0.000754	0.013	CbGpPWpGaD
Dicoumarol—VKORC1—Post-translational protein modification—ST6GAL1—esophageal cancer	0.000724	0.0125	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.000722	0.0124	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ABL1—esophageal cancer	0.000703	0.0121	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—ABL1—esophageal cancer	0.000693	0.0119	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—BAX—esophageal cancer	0.000635	0.0109	CbGpPWpGaD
Dicoumarol—NQO1—Transcriptional activation by NRF2—PIK3CA—esophageal cancer	0.00063	0.0108	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—ABCC2—esophageal cancer	0.000571	0.00983	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—NFE2L2—esophageal cancer	0.000531	0.00914	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000508	0.00875	CbGpPWpGaD
Dicoumarol—CYP2C9—Xenobiotics—CYP2A6—esophageal cancer	0.000494	0.00851	CbGpPWpGaD
Dicoumarol—CYP2C9—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000475	0.00819	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—CYP2A6—esophageal cancer	0.000456	0.00786	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000454	0.00781	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000454	0.00781	CbGpPWpGaD
Dicoumarol—VKORC1—Post-translational protein modification—CALR—esophageal cancer	0.000437	0.00752	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000424	0.00731	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.000418	0.00719	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000404	0.00696	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—XBP1—esophageal cancer	0.000398	0.00686	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—esophageal cancer	0.000393	0.00677	CbGpPWpGaD
Dicoumarol—CYP2C9—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000383	0.0066	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—SLC30A7—esophageal cancer	0.000382	0.00657	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000365	0.00629	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.000348	0.006	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.000348	0.006	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000347	0.00598	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000347	0.00598	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000344	0.00592	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000339	0.00584	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—esophageal cancer	0.000326	0.00561	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.000325	0.00559	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN1A—esophageal cancer	0.000321	0.00553	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—TGFBR2—esophageal cancer	0.00032	0.00551	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—HMOX1—esophageal cancer	0.000316	0.00544	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—esophageal cancer	0.000306	0.00526	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000303	0.00521	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000296	0.0051	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000296	0.0051	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000288	0.00496	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000286	0.00493	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000284	0.00489	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000251	0.00433	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—ACTB—esophageal cancer	0.000237	0.00408	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000233	0.00402	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000225	0.00388	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.000225	0.00388	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000215	0.0037	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—HSPA5—esophageal cancer	0.000214	0.00368	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CALR—esophageal cancer	0.000207	0.00357	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000205	0.00353	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—GHRL—esophageal cancer	0.000204	0.00351	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000202	0.00349	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—FBXW7—esophageal cancer	0.0002	0.00345	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.000191	0.0033	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000177	0.00305	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000166	0.00287	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000165	0.00285	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000163	0.00281	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SLC52A3—esophageal cancer	0.000163	0.00281	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—BLVRB—esophageal cancer	0.000163	0.00281	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000158	0.00272	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000156	0.00268	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000153	0.00264	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.000152	0.00262	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CA1—esophageal cancer	0.000139	0.00239	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SLC10A2—esophageal cancer	0.000139	0.00239	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000134	0.00231	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.000133	0.0023	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CA2—esophageal cancer	0.000127	0.00218	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000126	0.00217	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000124	0.00214	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000122	0.00211	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PLCE1—esophageal cancer	0.000118	0.00203	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ADH7—esophageal cancer	0.000118	0.00203	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000115	0.00199	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000114	0.00196	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ADH1B—esophageal cancer	0.000103	0.00178	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—TYMP—esophageal cancer	9.87e-05	0.0017	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP26A1—esophageal cancer	9.61e-05	0.00165	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	9.4e-05	0.00162	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ALOX15—esophageal cancer	9.36e-05	0.00161	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	8.94e-05	0.00154	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—TPI1—esophageal cancer	8.93e-05	0.00154	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTO1—esophageal cancer	8.93e-05	0.00154	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	8.84e-05	0.00152	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	8.62e-05	0.00149	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ALDOB—esophageal cancer	8.56e-05	0.00147	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	8.38e-05	0.00144	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GAPDH—esophageal cancer	8.24e-05	0.00142	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CRABP1—esophageal cancer	8.17e-05	0.00141	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GNG7—esophageal cancer	7.77e-05	0.00134	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ALDH2—esophageal cancer	7.28e-05	0.00125	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	7.12e-05	0.00123	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	7.02e-05	0.00121	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTT1—esophageal cancer	6.92e-05	0.00119	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	6.87e-05	0.00118	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP2A6—esophageal cancer	6.84e-05	0.00118	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	6.7e-05	0.00115	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	6.6e-05	0.00114	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ENO1—esophageal cancer	6.49e-05	0.00112	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTGS1—esophageal cancer	6.49e-05	0.00112	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PSME2—esophageal cancer	6.39e-05	0.0011	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PSME1—esophageal cancer	6.39e-05	0.0011	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP1B1—esophageal cancer	5.52e-05	0.00095	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP19A1—esophageal cancer	5.19e-05	0.000893	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—HMOX1—esophageal cancer	4.73e-05	0.000815	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.64e-05	0.000799	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ABCB1—esophageal cancer	4.54e-05	0.000783	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.05e-05	0.000697	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SLC52A3—esophageal cancer	3.6e-05	0.00062	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—BLVRB—esophageal cancer	3.6e-05	0.00062	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.22e-05	0.000554	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SLC10A2—esophageal cancer	3.06e-05	0.000527	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CA1—esophageal cancer	3.06e-05	0.000527	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CREBBP—esophageal cancer	3.04e-05	0.000523	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CA2—esophageal cancer	2.8e-05	0.000482	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.73e-05	0.000471	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NOS3—esophageal cancer	2.72e-05	0.000468	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ADH7—esophageal cancer	2.6e-05	0.000448	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.6e-05	0.000448	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.57e-05	0.000443	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTGS2—esophageal cancer	2.49e-05	0.000428	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.28e-05	0.000393	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—TYMP—esophageal cancer	2.18e-05	0.000375	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.12e-05	0.000365	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—EP300—esophageal cancer	2.07e-05	0.000356	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.07e-05	0.000356	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.97e-05	0.00034	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—TPI1—esophageal cancer	1.97e-05	0.00034	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.89e-05	0.000326	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.82e-05	0.000313	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.8e-05	0.000311	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GNG7—esophageal cancer	1.72e-05	0.000295	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.61e-05	0.000277	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CA—esophageal cancer	1.53e-05	0.000263	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.53e-05	0.000263	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.51e-05	0.00026	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.51e-05	0.000259	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ENO1—esophageal cancer	1.43e-05	0.000247	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.43e-05	0.000247	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PSME2—esophageal cancer	1.41e-05	0.000243	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PSME1—esophageal cancer	1.41e-05	0.000243	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.23e-05	0.000212	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.22e-05	0.00021	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.15e-05	0.000197	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.05e-05	0.00018	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.03e-05	0.000177	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ABCB1—esophageal cancer	1e-05	0.000173	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.58e-06	0.000131	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.7e-06	0.000115	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NOS3—esophageal cancer	6e-06	0.000103	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTGS2—esophageal cancer	5.49e-06	9.46e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—EP300—esophageal cancer	4.57e-06	7.86e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.38e-06	5.82e-05	CbGpPWpGaD
